Effect of different disease-modifying therapies on humoral response to BNT162b2 vaccine in Sardinian multiple sclerosis patients

Maristella Pitzalis(Institute of Genetic and Biomedical Research), Francesco Cucca(University of Sassari), Francesca Virdis(Institute of Genetic and Biomedical Research), Maristella Steri(Institute of Genetic and Biomedical Research), Annalisa Loizedda(Institute of Genetic and Biomedical Research), Maria Fronza(University of Cagliari), Monia Lobina(Institute of Genetic and Biomedical Research), Federica Loi(Istituto Zooprofilattico Sperimentale della Sardegna), M. Marini(Institute of Genetic and Biomedical Research), Jessica Frau(University of Cagliari), Paolo Solla(University of Sassari), Lorena Lorefice(University of Cagliari), Matteo Floris(University of Sassari), Valeria Lodde(University of Sassari), Valeria Orrù(Institute of Genetic and Biomedical Research), Maura Mingoia(Institute of Genetic and Biomedical Research), Giuseppe Delogu(Sapienza University of Rome), Elisa Carta(University of Cagliari), Maria Laura Idda(University of Cambridge), Marcella Devoto(Children's Hospital of Philadelphia), Sergio Uzzau(University of Sassari), Daniele Carmagini(University of Cagliari), Federica Pirinu(University of Sassari), Eleonora Cocco(University of Cagliari), Magdalena Zoledzwieska(National Academies of Sciences, Engineering, and Medicine), Edoardo Fiorillo(Institute of Genetic and Biomedical Research), Ignazio Roberto Zarbo(University of Sassari)
medRxiv
September 27, 2021
Cited by 6


Related Papers